Glycemic control and hypoglycemia

Diabetes Care

Volumn 31, Issue 10, 2008, Pages 2072-2076

  Perlmuter, Lawrence C ^a   Flanagan, Brian P ^b   Shah, Parinda H ^b   Singh, Sant P ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMPA RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCAGON; GLUCOSE; GROWTH HORMONE; HUMAN INSULIN; HYDROCORTISONE; LEVOTHYROXINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA;

ANXIETY; AUTONOMIC NERVOUS SYSTEM; BRAIN ISCHEMIA; CELL DEATH; COGNITIVE DEFECT; DECLARATIVE MEMORY; DEPRESSION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; TEMPORAL LOBE; ADOLESCENT; BEHAVIOR THERAPY; CHEMICALLY INDUCED DISORDER; CONFUSION; FEAR; HOMEOSTASIS; HYPERGLYCEMIA; LIFESTYLE; METABOLISM; NOTE; PSYCHOLOGICAL ASPECT;

ADOLESCENT; BEHAVIOR THERAPY; BLOOD GLUCOSE; COGNITION DISORDERS; CONFUSION; FEAR; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; LIFE STYLE;

EID: 56149117395     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1441     Document Type: Review

References (63)

1. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care 24:1858-1862, 2001
2. Gross TM, Mastrototaro JJ, FredricksonLP: Detection of unseen hypoglycemia using continuous glucose monitoring (Abstract). Diabetología 43:A5, 2001
3. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, the DARTS/MEMO Collaboration: Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population based study. Όiabet Meά 22:749-755, 2005
4. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26: 1902-1912, 2003
5. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI: Local ventromedial hy-pothalamus glucopenia triggers counter-regulatory hormone release. Diabetes 44: 180-184, 1995
6. Mitrakou A, Ryan C, Veneman T, Mo-kan M, Jenssen T, Kiss I, Durrant J, Cryer P, GerichJ: Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am] Physíol 260:E67-E74, 1991
7. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxi-dase. JCίin Invest 117:910-918, 2007
8. McAulay V, Deary IJ, Frier BM: Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18:690-705, 2001
9. Banarer S, Cryer PE: Sleep-related hypo-glycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 53: 1195-1203,2003
10. Allen KV, Frier BM: Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract 9:530-543, 2003
11. Sovik O, Thordarson H: Dead-in-bed syndrome in young diabetic patients. Diabetes Care 22 (Suppl. 2):B40-B42, 1999
12. Davis EA, KeatingB, Byrne GC, Russell M, Jones TW: Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 20:22-25, 1997
13. Davis SN, Shavers C, Costa F: Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans. J Clín Endocrínol Metab 85:2148-2157,2000
14. Heller SR, Cryer PE: Reduced neuroendo-crine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 4:223-226, 1991
15. Cryer PE: Hypoglycemia begets hypoglycemia in IDDM. Diabetes 42:1691-1693, 1993
16. Diedrich L, Sandoval D, Davis SN: Hypoglycemia associated autonomic failure. Clín AutonRes 12:358-365, 2002
17. Bussau VA, Ferreira LD, Jones TW, Fournier PA: The 10-s maximal sprint: a novel approach to counter an exercise-mediated íall in glycemia in individuals with type 1 diabetes. Diabetes Care 29: 601-606, 2006
18. Bussau VA, Ferreira LD, Jones TW, Fournier PA: A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise íall in glycaemia in individuals with type 1 diabetes. Día- betología 50:1815-1818, 2007
19. Patton SR, Dolan LM, Henry R, Powers SW: Parental íear oí hypoglycemia: young children treated with continuous subcutaneous insulin iníusion. Pedíatr Diabetes 8:362-368, 2007
20. Gonder-Frederick L, Cox D, Kovatchev B, Julian D, Clarke W: The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM. Diabetes Care 20:1543-1546, 1997
21. Cryer PE: Hypoglycemia: the limiting lac-tor in the management of IDDM. Diabetes 43:1378-1389, 1994
22. Surwit RS, Schneider MS, Feinglos MN: Stress and diabetes mellitus. Diabetes Care 15:1413-1422, 1992
23. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect oí intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
24. Umino Y, Everhart D, Solessio E, Cusato K, Pan JC, Nguyen TH, Brown ET, Hafler R, Frio BA, Knox BE, Engbretson GA, Haeri M, Cui L, Glenn AS, Charron MJ, Barlow RB: Hypoglycemia leads to age-related loss of vision. Proc Natl Acad Sci USA 103:19541-19545, 2006
25. Gass P, Katsura K, Zuschratter W, Siesjo B, Kiessling M: Hypoglycemia-elicited immediate early gene expression in neurons and glia oí the hippocampus: novel patterns of FOS, JUN and KROX expression following excitotoxic injury. J Cereb Blood Flow Metab 15:989-1001, 1995
26. Ho MS, Weller NJ, Ives FJ, Carne CL, Murray K, Vanden Driesen RI, Nguyen TP, Robins PD, Bulsara M, Davis EA, Jones TW: Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J Pedíatr. 25 April 2008 [Epub ahead of print]
27. Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM: Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-íor-gestational-age preterm infants. J Pedíatr 134:492-498, 1999
28. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
29. Laing SP, Swerdlow AJ, Slater SD, BothaJL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus. Díabet Med 16:466-471, 1999
30. Warren RE, Frier BM: Hypoglycaemia and cognitive function. Diabetes Obes Metab 7:493-503, 2005
31. Herings RM, de Boer A, Strieker BH, Leufkens HG, Porsius A: Hypoglycaemia associated with use of inhibitors of angio-tensin converting enzyme. Lancet 345: 1195-8, 1995
32. Otto-Buczkowska E, Jarosz-Chobot P, Tucholski K: New developments in the treatment of type 1 diabetes mellitus. En-dokrynol Pol 59:246-253, 2008 [in Polish]
33. Feldman J, Barshi I: The Effects of Blood Glucose Levels on Cognitive Performance: a Review of Literature. Moffett Field, California, NASA Ames Research Center, 2007 (NASA/TM-2007-214555)
34. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteins-son B: Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Dia-betologia 46:89-96, 2003
35. Hirai FE, Moss SE, Klein BE, Klein RK: Severe hypoglycemia and smoking in a long-term type 1 diabetic population Wisconsin epidemiologic study of diabetic retinopathy. Diabetes Cαre30:1437-1441, 2007
36. Strachan MW, Deary IJ, Ewing FM, Frier BM: Recovery of cognitive íunction and mood alter severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23:305-312, 2000
37. Hoffman RG, Speelman DJ, Hinnen DA, Conley KL, Guthrie RA, Knapp RK: Changes in cortical íunctioning with acute hypoglycemia and hyperglycemia in type 1 diabetes. Diabetes Care 12:193-197, 1989
38. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA: Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 23:893-897, 2000
39. McAulay V, Deary IJ, Ferguson SC, Frier BM: Acute hypoglycemia in humans causes attentional dysíunction while nonverbal intelligence is preserved. Diabetes Care 24:1745-17'50, 2001
40. Sommerfield AJ, Deary IJ, McAulay V, Frier BM: Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care 26:390-396, 2003
41. Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV: Enhanced adrenomedullary response and increased susceptibility to neuroglycope-nia: mechanisms underlying the adverseeffects of sugar ingestion in healthy children. J Pedíatr 126:171-177, 1995
42. Fanelli CG, Pampanelli S, Porcellati F, Bartocci L, Scionti L, Rossetti P, Bolll GB: Rate of íall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive íunction to hypoglycaemia in type 1 diabetes mellitus in the postprandial state. Diabetología 46:53-64, 2003
43. Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bay less M, Silvers N, HarthJ, White N, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group: The impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care 31:1933-1938, 2008
44. DCCT Research Group: DCCT protocol. Springfield, Virginia, Department of Commerce, National Technical Information Service, 1988 (publ. no. NIH 88-116462-AS)
45. Langan SJ, Deary IJ, Hepburn DA, Frier BM: Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Díabetologia 34:337-344, 1991
46. Alkalay AL, Flores-Sarnat L, Sarnat HB, Moser FG, Simmons CF: Brain imaging findings in neonatal hypoglycemia: case report and review of 23 cases. Clin Pedíatr 44:783-790, 2005
47. Kauiman FR, Epport K, Engilman R, Hal-vorson M: Neurocognitive íunctioning in children diagnosed with diabetes before age 10 years. ] Diabetes Complications 13: 31-38, 1999
48. Rovet J, Alvarez M: Attentional functioning in children and adolescents with IDDM. Diabetes Care 20:803-810, 1997
49. Rovet JF, Ehrlich RM: The effect of hypoglycemic seizures on cognitive íunction in children with diabetes: a 7-year prospective study. J Pediatr 134:503-506, 1999
50. Wysocki T, Harris MA, Mauras N, Fox L, Taylor A, Jackson SC, White NH: Absence of adverse effects oí severe hypoglycemia on cognitive íunction in school-aged children with diabetes over 18 months. Diabetes Care 26:1100-1105, 2003
51. Hershey T, Craft S, Bhargava N, White N: Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. J lnt Neuro-psycholSoc 3:509-520, 1997
52. Hershey T, Bhargava N, Sadler M, White NH, Craft S: Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care 22:1318-1324, 1999
53. Jauch-Chara K, Hallschmid M, Gais S, Schmid SM, Oltmanns KM, ColmorgenC, BornJ, Schultes B: Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care 30:2040-2045, 2007
54. Young SE, Mainous AG 3rd, Carnemolla M: Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 29:2688-2693, 2006
55. Wright RJ, Frier BM: Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabete Metab Res Rev 24:353-363, 2008
56. Koivikko ML, Karsikas M, Salmela PI, Tapanainen JS, RuokonenA, SeppanenT, Huikuri HV, Perkiomaki JS: Effects of controlled hypoglycaemia on cardiac re-polarisation in patients with type 1 diabetes. Ό iabetologia 51:426-435, 2008
57. Robinson RT, Harris ND, Ireland RH,Macdonald IA, Heller SR: Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes. Όiabetologia 47:312-315, 2004
58. Derijks HJ, Heerdink ER De Koning FH, Janknegt R, Klungel OH, Egberts AC: The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepí-demíol Drug Saf 17:336-344, 2008
59. Iihara N, Kurosaki Y, Takada M, Morita S: Risk of hypoglycemia associated with thyroid agents is increased in patients with liver impairment, lnt J Clin Pharmacol Ther 46:1-13,2008
60. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill \JB, Peterson GE, Mudaliar SR, Reinhardt RR: Continuous subcutaneous insulin infusion and multi-ple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26:2598-2603, 2003
61. Holstein A, Plaschke A, Egberts EH: Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 17:467-473, 2001
62. Abdelmalik PA, Shannon P, Yiu A, Liang P, Adamchik Y, Weisspapir M, Samoilova M, Burnham WM, Carlen PL: Hypoglyce-mic seizures during transient hypoglycemia exacerbate hippocampal dysfunction. Neurobiol Dis 26:646-660, 2007
63. Nellgard B, Wieloch T: Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 92:259-266, 1992